|
Pharmaceutical Products – Delivery Of Medicinal Products For The Needs Of The Departments Of Czerniakowski Hospital Sp. Z O. O. Package No. 1 - Cinacalcet, A Reimbursed Medicinal Product In Poland Treatment Of Secondary Hyperparathyroidism In Hemodialysis Patients B39, In Accordance With The Announcement Of The Ministry Of Health,Package No. 2 - Ranibizumab - A Reimbursed Medicinal Product In Poland Treatment Of Patients With B.70 Retinal Diseases, In Accordance With The Announcement Of The Ministry Of Health,Package No. 3 - Aflibercept - A Reimbursed Medicinal Product In Poland Treatment Of Patients With B.70 Retinal Diseases, In Accordance With The Announcement Of The Ministry Of Health,Package No. 4 - Faricymab - A Reimbursed Medicinal Product In Poland Treatment Of Patients With B.70 Retinal Diseases, In Accordance With The Announcement Of The Ministry Of Health,Package No. 5 - Dexamethasoneum - A Reimbursed Medicinal Product In Poland Treatment Of Patients With B.70 Retinal Diseases, In Accordance With The Announcement Of The Ministry Of Health,Package No. 6 - Brolucizumab - A Medicinal Product Reimbursed In Poland Treatment Of Patients With B.70 Retinal Diseases, In Accordance With The Announcement Of The Ministry Of Health,Package No. 7 - Bevacizumab - A Medicinal Product Reimbursed In Poland Treatment Of Patients With B.70 Retinal Diseases, In Accordance With The Announcement Of The Ministry Of Health,Package No. 8 - Interferon Beta - 1B Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 9 - Interferon Beta - 1A Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 10 - Interferon Beta - 1A Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 11 - Peginterferon Beta - 1A Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 12 - Dimethyl Fumarate - 1A Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 13 - Botulinum Toxin A - Reimbursed Medicinal Product In Poland Treatment Of Focal Dystonia And Hemifacial Spasm B.28, In Accordance With The Announcement Of The Ministry Of Health,Package No. 14 - Ofatumumabum - Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 15 - Siponimodum - Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 16 - Human Immunoglobulin - A Reimbursed Medicinal Product In Poland Treatment With Immunoglobulin Transfusions In Neurological Diseases,Package No. 17 - Natalizumab - A Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 18 - Ozanimodum - A Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Package No. 19 - Glatiramer Acetate - Reimbursed Medicinal Product In Poland Treatment Of Multiple Sclerosis B.29, In Accordance With The Announcement Of The Ministry Of Health,Pack
|
